Carl Zeiss Meditec AG (ETR:AFX) has earned a consensus rating of “Hold” from the seven research firms that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating on the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is €45.75 ($53.82).

AFX has been the topic of a number of recent analyst reports. Deutsche Bank AG set a €36.00 ($42.35) price target on shares of Carl Zeiss Meditec AG and gave the stock a “neutral” rating in a report on Monday, June 26th. Nord/LB set a €52.00 ($61.18) price target on shares of Carl Zeiss Meditec AG and gave the stock a “buy” rating in a report on Friday, June 2nd. Independent Research GmbH set a €44.00 ($51.76) price target on shares of Carl Zeiss Meditec AG and gave the stock a “neutral” rating in a report on Saturday, May 20th. Commerzbank Ag set a €42.00 ($49.41) price target on shares of Carl Zeiss Meditec AG and gave the stock a “neutral” rating in a report on Saturday, May 20th. Finally, Berenberg Bank set a €48.00 ($56.47) price target on shares of Carl Zeiss Meditec AG and gave the stock a “buy” rating in a report on Monday, May 29th.

Carl Zeiss Meditec AG (ETR AFX) traded down 0.82% during mid-day trading on Tuesday, hitting €42.20. 520 shares of the company’s stock were exchanged. Carl Zeiss Meditec AG has a 12 month low of €30.80 and a 12 month high of €47.80. The stock’s 50 day moving average price is €44.39 and its 200-day moving average price is €42.68. The stock has a market cap of €3.77 billion and a PE ratio of 28.51.

TRADEMARK VIOLATION NOTICE: “Carl Zeiss Meditec AG (AFX) Receives €45.75 Average Price Target from Brokerages” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this report on another site, it was stolen and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://www.thecerbatgem.com/2017/08/21/carl-zeiss-meditec-ag-afx-receives-45-75-average-price-target-from-brokerages.html.

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery.

Analyst Recommendations for Carl Zeiss Meditec AG (ETR:AFX)

Receive News & Stock Ratings for Carl Zeiss Meditec AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec AG and related stocks with our FREE daily email newsletter.